Lv11
20 积分 2024-10-25 加入
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
7小时前
已完结
Reactive oxygen species in cancer: a paradox between pro- and anti-tumour activities
1个月前
已完结
Targeting ROS in cancer: rationale and strategies
1个月前
已完结
Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression
5个月前
已完结
The role of ROS in tumour development and progression
5个月前
已完结
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
5个月前
已完结
皖公网安备34019202002308
